New oral antiviral drug to be used for treatment of COVID-19
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- Former director of religious affairs pleads guilty for bribery
- All-aboard! 11-Day tourist train circles Qinghai, Gansu, Xizang
- 149,000 cases filed this year in anti-graft campaign
- Nepali resident marks milestone as 10,000th Letse Port passenger
- China expresses concerns over expansion of Australia-UK-US pact in Asia-Pacific
- Chongqing celebrates World Book Day with subway book machines